HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elastin stabilizes an infarct and preserves ventricular function.

AbstractBACKGROUND:
After a myocardial infarction, the injured region becomes fibrotic and the myocardial scar may expand if the ventricular wall lacks elasticity. Cardiac dilatation may precipitate the vicious cycle of progressive heart failure. The present study evaluated the functional benefits of increasing elastin within a myocardial scar using cell based gene therapy.
METHODS AND RESULTS:
A myocardial infarction was generated by ligation of the left anterior descending artery in rats. Six days later, 2 x 10(6) syngeneic rat endothelial cells transfected with the rat elastin gene (elastin group, n=14) or an empty plasmid (control group, n=14) were transplanted into the infarct scar. Cardiac function, left ventricular (LV) volume, and infarct size were monitored over 3 months by echocardiography, Langendorff measurements, and planimetry. Elastin deposition was evaluated in the cells and in the infarct region by Western blot assay and by histological examination. Recombinant elastin was found in the scar in the elastin group but not the control group during the 3 months after cell transplantation. Histological assessment demonstrated organized elastic fibers within the infarct region. LV volume and infarct size were significantly smaller (P<0.05) in the elastin group than in the control group. Cardiac function evaluated by echocardiography and during Langendorff perfusion was significantly better (P<0.05) in the elastin group than in the control group.
CONCLUSIONS:
Expressing recombinant elastin within the myocardial scar reduced scar expansion and prevented LV enlargement after a myocardial infarction. Altering matrix remodeling after an infarct preserved the LV function for at least 3 months.
AuthorsTomohiro Mizuno, Terrence M Yau, Richard D Weisel, Chris G Kiani, Ren-Ke Li
JournalCirculation (Circulation) Vol. 112 Issue 9 Suppl Pg. I81-8 (Aug 30 2005) ISSN: 1524-4539 [Electronic] United States
PMID16159870 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Recombinant Fusion Proteins
  • Elastin
Topics
  • Animals
  • Cells, Cultured (metabolism, transplantation)
  • Cicatrix (metabolism, pathology)
  • Drug Evaluation, Preclinical
  • Elastin (genetics, physiology)
  • Endothelial Cells (metabolism, transplantation)
  • Extracellular Matrix (ultrastructure)
  • Genetic Therapy
  • Heart Failure (etiology, prevention & control)
  • Hypertrophy, Left Ventricular (etiology, prevention & control)
  • Male
  • Myocardial Infarction (complications, diagnostic imaging, pathology, physiopathology, therapy)
  • Myocardium (chemistry, pathology)
  • Random Allocation
  • Rats
  • Rats, Inbred Lew
  • Recombinant Fusion Proteins (analysis, biosynthesis, physiology)
  • Single-Blind Method
  • Transfection
  • Ultrasonography
  • Ventricular Function, Left (physiology)
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: